Acadia Healthcare (NASDAQ:ACHC) Updates FY 2025 Earnings Guidance

Acadia Healthcare (NASDAQ:ACHC) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided earnings per share guidance of 2.500-2.800 for the period, compared to the consensus earnings per share estimate of 2.66. The company issued revenue guidance of $3.3 billion-$3.4 billion, compared to the consensus revenue estimate of $3.3 billion.

Acadia Healthcare Trading Up 8.4%

Shares of Acadia Healthcare stock traded up $2.00 during trading hours on Monday, reaching $25.84. 3,426,594 shares of the company’s stock were exchanged, compared to its average volume of 1,654,715. Acadia Healthcare has a 52-week low of $20.36 and a 52-week high of $82.41. The firm has a market capitalization of $2.38 billion, a price-to-earnings ratio of 8.47, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. The company has a fifty day moving average of $26.57 and a 200-day moving average of $36.32. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.02). Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Sell-side analysts forecast that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Barclays downgraded Acadia Healthcare from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $43.00 to $35.00 in a report on Friday, February 28th. Royal Bank of Canada lowered their price target on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a report on Monday, March 3rd. KeyCorp lowered their price target on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a report on Monday, March 3rd. Bank of America lowered their price target on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a report on Friday, February 28th. Finally, Guggenheim initiated coverage on Acadia Healthcare in a report on Wednesday, April 9th. They issued a “buy” rating and a $36.00 price target for the company. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $50.39.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.